Adam Mead

Adam Mead

University of Oxford

H-index: 52

Europe-United Kingdom

About Adam Mead

Adam Mead, With an exceptional h-index of 52 and a recent h-index of 46 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of Haematology, Stem Cell Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts

Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib

Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline

Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis

The management of myelofibrosis: a British Society for Haematology Guideline

Meaningful symptomatic change in patients with myelofibrosis from the SIMPLIFY studies

Backtracking to the future: unraveling the origins of childhood leukemia

S167: EFFICACY AND SAFETY OF LUSPATERCEPT FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MYELOFIBROSIS: RESULTS FROM THE ACE-536-MF-001 STUDY

Adam Mead Information

University

Position

___

Citations(all)

11356

Citations(since 2020)

7345

Cited By

6562

hIndex(all)

52

hIndex(since 2020)

46

i10Index(all)

113

i10Index(since 2020)

100

Email

University Profile Page

University of Oxford

Google Scholar

View Google Scholar Profile

Adam Mead Skills & Research Interests

Haematology

Stem Cell Biology

Top articles of Adam Mead

Title

Journal

Author(s)

Publication Date

Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts

Cancer Research

Pedro L Moura

Teresa Mortera-Blanco

Isabel J Hofman

Gabriele Todisco

Warren W Kretzschmar

...

2024/1/16

Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib

Blood

Alex Rampotas

Luke Carter-Brzezinski

Tim CP Somervaille

James Forryan

Fotios Panitsas

...

2024/1/11

Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline

British journal of haematology

Donal P McLornan

Anna L Godfrey

Anna Green

Rebecca Frewin

Siamak Arami

...

2024/1

Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis

Ejhaem

Stephen T Oh

Srdan Verstovsek

Vikas Gupta

Uwe Platzbecker

Timothy Devos

...

2024/2/5

The management of myelofibrosis: a British Society for Haematology Guideline

British journal of haematology

Donal P McLornan

Bethan Psaila

Joanne Ewing

Andrew Innes

Siamak Arami

...

2024/1

Meaningful symptomatic change in patients with myelofibrosis from the SIMPLIFY studies

Value in Health

Stacie Hudgens

Srdan Verstovsek

Lysbeth Floden

Claire N Harrison

Jeanne Palmer

...

2024/2/2

Backtracking to the future: unraveling the origins of childhood leukemia

Leukemia

Adam J de Smith

Joseph L Wiemels

Adam J Mead

Irene Roberts

Anindita Roy

...

2024/2

S167: EFFICACY AND SAFETY OF LUSPATERCEPT FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MYELOFIBROSIS: RESULTS FROM THE ACE-536-MF-001 STUDY

HemaSphere

Aaron T Gerds

Claire Harrison

Jean-Jacques Kiladjian

Ruben Mesa

Alessandro Vannucchi

...

2023/8/1

A Multiomic Single-Cell Atlas of Human Myelopoiesis Reveals Cellular and Molecular Drivers of Immunomodulatory Drug-Induced Neutropenia

Blood

Christina Simoglou Karali

Simone Riva

Sally-Ann Clark

Sean Wen

Nikolaos Sousos

...

2023/11/2

Multiparametric MRI detects multi-organ impairment in patients with chronic myeloid neoplasms with normal serum biomarkers.

medRxiv

Sophie Reed

Charlie Diamond

Samiya Mahmood

Soubera Rymell

Michael Smith

...

2023

Single-Cell Mutation Profiling and Alternative Splicing Analysis Reveals Distinct Aberrant Splicing of U2AF1 S34 and U2AF1 Q157 in Myeloid Malignancies

Blood

Sean Wen

Jennifer O Sullivan

Joanna Baxter

Nikolaos Sousos

Adam J Mead

...

2023/11/28

MARVEL: an integrated alternative splicing analysis platform for single-cell RNA sequencing data

Nucleic Acids Research

Wei Xiong Wen

Adam J Mead

Supat Thongjuea

2023/3/21

CNL and aCML should be considered as a single entity based on molecular profiles and outcomes

Blood Advances

Gonzalo Carreño-Tarragona

Alberto Álvarez-Larrán

Claire Harrison

José Carlos Martínez-Ávila

Juan Carlos Hernández-Boluda

...

2023/5/9

Cooperation between SF3B1 and JAK2 V617F Mutations Accelerates Fibrotic Progression in Myeloproliferative Neoplasms By Enhancing STAT1 Signaling

Blood

Jennifer O Sullivan

Sean Wen

Affaf Aliouat

Alba Rodriguez-Meira

Sally-Ann Clark

...

2023/11/28

S168: PELABRESIB (CPI-0610) MONOTHERAPY IN PATIENTS WITH HIGH-RISK ESSENTIAL THROMBOCYTHEMIA REFRACTORY OR INTOLERANT TO HYDROXYUREA: PRELIMINARY RESULTS FROM MANIFEST STUDY

HemaSphere

Francesco Passamonti

Andrea Patriarca

Steven Knapper

Candido Rivera

Joseph M Scandura

...

2023/8/1

3031–Chromothripsis and leukemic transformation in MPN

Experimental Hematology

Charlotte Brierley

Bon Ham Yip

Giulia Orlando

Harsh Goyal

Sean Wen

...

2023/1/1

Patient-reported outcomes and quality of life in anemic and symptomatic patients with myelofibrosis: results from the MOMENTUM Study

HemaSphere

Ruben A Mesa

Claire Harrison

Jeanne M Palmer

Vikas Gupta

Donal P McLornan

...

2023/11/1

Promise: Investigation into the Combination of a Potent Beti with Ruxolitinib in Patients with High or Intermediate-2 Risk Myelofibrosis Not Receiving an Adequate Response with …

Blood

Adam J Mead

Claire N Harrison

Brian Huntly

Bethan Psaila

Rebecca Boucher

...

2023/11/28

Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy

Blood

Annatina S Schnegg-Kaufmann

Julie AI Thoms

Golam Sarower Bhuyan

Henry R Hampton

Lachlin Vaughan

...

2023/3/16

Accelerated RNA splicing dynamics during erythroid differentiation amplify mis-splicing in SF3B1-mutant MDS-RS

Leukemia Research

A Mead

P Moura

T Mortera-Blanco

I Hofman

G Todisco

...

2023/5/1

See List of Professors in Adam Mead University(University of Oxford)